Events

Recall of COBAS INTEGRA THEOPHYLLINE FOR COBAS C SYSTEMS

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS GMBH.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    95558
  • Event Risk Class
    III
  • Event Initiated Date
    2011-12-19
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Changes in the specification in the instructions for use of the theophylline test. the new lower detection limit is 0.8 ug/ml - 40 ug/ml. the theobromine concentration in section "limitations-inteference" of the instrusctions for use has been modified to 20 ug/ml.

Device

COBAS INTEGRA THEOPHYLLINE FOR COBAS C SYSTEMS
  • Model / Serial
    Model Catalog: 04491025190 (Lot serial: ALL LOTS); Model Catalog: 03800474190 (Lot serial: ALL LOTS)
  • Product Description
    COBAS INTEGRA THEOPHYLLINE FOR COBAS C SYSTEMS
  • Manufacturer
    ROCHE DIAGNOSTICS GMBH

Manufacturer

ROCHE DIAGNOSTICS GMBH
  • Manufacturer Address
    MANNHEIM
  • Manufacturer Parent Company (2017)
    Roche Holding AG
  • Source
    HC